Literature DB >> 4962590

Sphingomyelinase in normal human spleens and in spleens from subjects with Niemann-Pick disease.

P B Schneider, E P Kennedy.   

Abstract

This paper describes the purification and some of the properties of an enzyme from human spleen that catalyzes the hydrolysis of sphingomyelin with the formation of ceramide and phosphoryl choline. The enzyme, which is located in the subcellular particulate fraction that sediments between 700 and 8500 g, is readily made soluble and has been partially purified. Its pH optimum is between 4.5 and 5.0. It is unaffected by divalent cations, chelating agents, and sulfhydryl reagents, but is inhibited by phosphate. The enzyme attacks sphingomyelin and dihydrosphingomyelin, but is inactive toward sphingosine phosphoryl choline, O-acetylsphingomyelin, and lecithin. In some of its properties, the enzyme from human spleen is different from the previously studied sphingomyelinase from rat tissues. The enzyme is absent or markedly reduced in spleens from patients with classical and visceral varieties of Niemann-Pick disease, but is present in normal amounts in the late infantile type of the disease. In the present study another enzyme, this one magnesium-dependent, capable of catalyzing the cleavage of sphingomyelin has been detected in the spleens of patients with the classical form of Niemann-Pick disease. Some implications of these findings for theories of the metabolic defect in Niemann-Pick disease are discussed.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4962590

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  64 in total

Review 1.  Basic findings and current developments in sphingolipidoses.

Authors:  H Pilz; R Heipertz; D Seidel
Journal:  Hum Genet       Date:  1979-03-12       Impact factor: 4.132

2.  Studies on sphingomyelinase activity in cultured cells and leucocytes.

Authors:  G T Besley
Journal:  J Inherit Metab Dis       Date:  1978       Impact factor: 4.982

Review 3.  The neutral sphingomyelinase family: identifying biochemical connections.

Authors:  Christopher J Clarke; Bill X Wu; Yusuf A Hannun
Journal:  Adv Enzyme Regul       Date:  2010-10-28

4.  Structure of cholesterol/ceramide monolayer mixtures: implications to the molecular organization of lipid rafts.

Authors:  Luana Scheffer; Inna Solomonov; Markus Jan Weygand; Kristian Kjaer; Leslie Leiserowitz; Lia Addadi
Journal:  Biophys J       Date:  2005-02-18       Impact factor: 4.033

5.  [Niemann-Pick disease (Crocker's type C): ultrastructural study of a case (author's transl)].

Authors:  J F Pellissier; J Hassoun; D Gambarelli; P A Bryon; P Casanova; M Toga
Journal:  Acta Neuropathol       Date:  1976-01-31       Impact factor: 17.088

6.  Niemann-Pick disease (Crocker's type C): A histological study of the distribution and qualitative differences fo the storage process.

Authors:  M Elleder; A Jirásek; F Smíd
Journal:  Acta Neuropathol       Date:  1975-12-19       Impact factor: 17.088

Review 7.  Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology.

Authors:  Catherine Pavoine; Françoise Pecker
Journal:  Cardiovasc Res       Date:  2009-01-28       Impact factor: 10.787

8.  Chemical studies on postmortem tissues from an infant with a sphingomyelin storage disorder.

Authors:  S F Donaghey; D N Raine; J E Crossley
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

9.  Niemann-Pick disease type C with enhanced glycolipid storage. Report on further case of so-called lactosylceramidosis.

Authors:  M Elleder; A Jirásek; F Smíd; J Ledvinová; G T Besley; M Stopeková
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

10.  Clinical and biochemical study of a child with the non-neuronopathic-Type B form of Niemann-Pick disease.

Authors:  D Reich; A Kedar; C Klibansky
Journal:  Eur J Pediatr       Date:  1979-05-18       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.